<DOC>
	<DOCNO>NCT01173536</DOCNO>
	<brief_summary>This Phase I , single-center , three-arm , randomize , double-blind , active- placebo-controlled study investigate effect GDC-0449 QT/QTc interval healthy female subject non-childbearing potential .</brief_summary>
	<brief_title>A Study Investigate Effect GDC-0449 QT/QTc Interval Healthy Female Subjects</brief_title>
	<detailed_description />
	<mesh_term>Moxifloxacin</mesh_term>
	<criteria>Female , 45 year age In good health , determine absence clinically significant finding screen visit Body mass index 18 32 kg/m^2 inclusive , body weight &gt; 45 kg Of nonchildbearing potential History clinically significant gastrointestinal , renal , hepatic , bronchopulmonary , neurological , psychiatric , cardiac , vascular , endocrinological , hematological , allergic disease ; metabolic disorder ; cancer ; cirrhosis Allergy moxifloxacin quinolone antibiotic confirm significant allergic reaction drug , multiple allergy judgment investigator Personal family history congenital long QT syndrome family history sudden death Participation investigational drug device study investigational drug within last 3 month six time elimination halflife , whichever longer , prior Day 1 study</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>